相关实验视频

Updated: Jun 15, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

慢性阻塞性肺病中的新标志物

Yonca Senem Akdeniz¹, Seda Özkan¹

¹Department of Emergency Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Türkiye.

Advances in clinical chemistry

|August 24, 2024

概括

确定慢性阻塞性肺病 (COPD) 恶化的可靠生物标志物对于更好的患者结果至关重要. 目前的标志物不足,需要研究这种呼吸道疾病的新诊断和预后工具.

科学领域:

肺部医学肺部医学
生物标志物发现发现
呼吸道疾病研究呼吸道疾病研究

背景情况:

慢性阻塞性肺病 (COPD) 显著影响全球健康和生活质量.
慢性肺炎的急性恶化会增加发病率和死亡率.
像CRP这样的现有生物标志物对于全面的COPD管理是不够的.

研究的目的:

审查COPD恶化的生物标志物发现方面的进展.
突出需要可靠的生物标志物用于诊断,预测和预后.
强调生物标志物在监测治疗反应和指导新疗法的作用.

主要方法:

对使用下一代分析技术用于生物标记物识别的最新研究进行审查.
在COPD的背景下分析已建立和新兴的生物标志物.
讨论对标准化临床验证的需要.

主要成果:

虽然已确立的标志物存在,但目前缺乏COPD恶化的通用生物标志物.
下一代分析正在揭示越来越多的潜在的新生物标志物.
在临床环境中进行标准化验证对于翻译研究结果至关重要.

结论:

有效的生物标志物对于改善COPD诊断,预后和治疗监测至关重要.
需要进一步的研究和标准化验证来识别和实施新的COPD生物标志物.
分析技术的进步为发现这种呼吸系统疾病更有效的生物标志物提供了有希望的途径.

关键词:

慢性慢性肺炎的急性发作急性恶化是急性的恶化.慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性肺炎.炎症炎症是一种炎症.炎症生物标志物炎症生物标志物炎症性细胞因子是炎症性细胞因子.炎症调解剂是一种炎症调解剂.新型生物标志物新型生物标志物慢性肺炎的发病原因慢性慢性肺炎的病理生理学

更多相关视频

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Published on: April 12, 2024

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: